Skip to Content

Swedish Real-World MS Data Demonstrates Long-Term Safety and Effectiveness of Cladribine

At ECTRIMS 2025, Linda Forsberg, Project Coordinator at the Department of Clinical Neuroscience, Karolinska Institutet, presented Swedish real-world data demonstrating the long-term safety and effectiveness of cladribine tablets in MS patients. The IMSE study showed stable or improved clinical outcomes, significant relapse reduction, and low treatment discontinuation over 36 months.

Linda Forsberg

Få adgang

Hvis du er læge, sygeplejerske eller anden sundhedsprofessionel kan du få adgang til hele artiklen ved at oprette en profil på BestPractice Nordic.

Back to top